How to Teach Pharmacogenomics

0.75 Continuing Education Credit Hours

0.75 AMA PRA Category 1 Credit(s)™

Category: Clinical Teaching - General

This module is an introduction for how to teach pharmacogenetics/genomics to clinicians. Part 1 of the module covers the need for clinical pharmacogenetic education, core elements to incorporate into your pharmacogenetic educational activities, and more resources on pharmacogenetic education. Part 2 of the module is an example of a pharmacogenetic educational activity, which was Cardiology Grand Rounds at the Ohio State University Wexner Medical Center.

Author

Jasmine Luzum, PharmD, PhD, BCPS

Dr. Jasmine (Talameh) Luzum, PharmD, PhD, BCPS joined the Department of Clinical Pharmacy in the College of Pharmacy at University of Michigan in July 2016. She received her PharmD summa cum laude from the University of Pittsburgh in 2008 and her PhD in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill Eshelman School of Pharmacy in 2013. She completed a Post-Doctoral Fellowship at the Ohio State University College of Medicine and Center for Pharmacogenomics in 2016. She became a Board-Certified Pharmacotherapy Specialist by the Board of Pharmacy Specialties and an Applied Pharmacologist by the American Board of Clinical Pharmacology in 2015.

Dr. Luzum’s long-term goal is to improve pharmacologic outcomes and reduce racial disparities in patients with cardiovascular disease, especially heart failure. She works to accomplish that goal using a variety of clinical & translational research approaches, with an emphasis on pharmacogenomics and bioinformatics. Her research has been funded by the most prestigious sponsors (e.g., NIH, American Heart Association, and American Foundation for Pharmaceutical Education), published in top journals (e.g., Cell Metabolism, Clinical Pharmacology & Therapeutics, Journal of the American Heart Association), and presented at major conferences (e.g., American College of Cardiology Scientific Sessions and the NIH Pharmacogenomics Research Network).   

Joseph Kitzmiller, M.D., PhD, FCP

Dr. Kitzmiller is Director of the Clinical Pharmacology & Pharmacogenomics Fellowship and Associate Director of the Center For Pharmacogenomics at OSUWMC. He is an NIH Translational Scholar in Pharmacogenomics and an Investigator at Ohio Clinical Trials. As part of OSU’s College of Medicine’s LSI education effort, Dr. Kitzmiller serves as an Education Portfolio Coach and provides lectures on clinical pharmacology and pharmacogenomics. As a certified physician investigator with the Association of Pharmaceutical Physician Investigators, his primary research effort involves investigating genetic influence on cardiovascular pharmacotherapies.

Objectives

  1. Describe the importance of clinical pharmacogenetics/genomics (PGx) education
  2. Incorporate the following five core elements into PGx educational activities: introduction to PGx, discipline-specific PGx examples, PGx patient case, practical considerations for PGx, and PGx information resources
  3. Locate additional clinical and educational PGx resources

Online Module

When completing the on-line module you will be presented with learning objectives, brief cases, questions for reflection (not scored), and interactive lessons with hyperlinks to engage you along the way. Once you complete the lessons, you will be presented with the Module Evaluation and then the Post Test (which requires a score of 70%), followed by the opportunity to print your Continuing Education Certificate. Modules remain available for your future reference once you have completed them.

Continuing Medical Education Disclosure

How to Teach Pharmacogenomics

Description

This enduring material will discuss the following:

How to Teach Pharmacogenomics

This module is an introduction for how to teach pharmacogenetics/genomics to clinicians. Part 1 of the module covers the need for clinical pharmacogenetic education, core elements to incorporate into your pharmacogenetic educational activities, and more resources on pharmacogenetic education. Part 2 of the module is an example of a pharmacogenetic educational activity, which was Cardiology Grand Rounds at the Ohio State University Wexner Medical Center.

Planning Committee

The following planning committee members have no relevant financial relationships with commercial interests to disclose.

John Mahan, MD

Heather Brod

Aubre Smith

 

John Mahan also discloses the following:

Grant/Research Support - Abbott Nutrition; Genentech

Consultant/Speaker Bureau - Abbott Nutrition

 

Heather Brod also discloses the following:

Advisory Board Membership –Healthcare Businesswomen’s Association  

 

Their educational unit does not have a financial interest or affiliation with an organization that may receive direct benefit from the subject of the proposed CME activity, and they will not be personally compensated for their role in the planning or execution of this proposed CME activity by an organization other than The Ohio State University:

John Mahan, MD

Heather Brod

Aubre Smith

 

Authors


Jasmine Luzum, PharmD, PhD, BCPS

Joseph Kitzmiller, M.D., PhD, FCP

 

 

Speaker Disclosures

The following presenters for this educational activity disclose that they have no relevant relationships with commercial interests to disclose.

Their presentations will not include discussion of unapproved or “off-label” usage of commercial products and/or services.

 

Jasmine Luzum, PharmD, PhD, BCPS

Joseph Kitzmiller, M.D., PhD, FCP

 

Dr. Kitmiller also discloses the following:

Grants/Research Support  - NIGMS K23 GM100372

 

Dr. Luzum also discloses the following:

Consultant/Speaker Bureau  - Consultant – Gnome Diagnostics, LLC

 

Gnome Diagnostics, LLC is a CLIA certified personal medicine company specialized in using genetic testing to safeguard the lives and health of patients, particularly in the area of cardiovascular diseases.

 

Objectives:

Participants who complete this module will be able to:

  1. Describe the importance of clinical pharmacogenetics/genomics (PGx) education
  2. Incorporate the following five core elements into PGx educational activities: introduction to PGx, discipline-specific PGx examples, PGx patient case, practical considerations for PGx, and PGx information resources
  3. Locate additional clinical and educational PGx resources

 

Accreditation Statement

The Ohio State University Center for Continuing Medical Education (CCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University Center for Continuing Medical Education designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit is only awarded after successful completion of post-test with a minimum of 75%.